Jubilant Ingrevia Ltd
JUBLINGREABSE 543271Specialty ChemicalsMkt cap ₹10,152 Cr
Whole group, including subsidiaries — the figures companies headline.
Revenue · Q1 FY27
₹1,300 Cr
YoY +25.3%QoQ +10.3%
Net profit · Q1 FY27
₹106 Cr
YoY +40.9%QoQ +22.4%
Net margin · Q1 FY27
8.1%
+0.9 pts vs Q1 FY26
Net profit · FY26
₹278 Cr
YoY +10.6%
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 1,300 | 1,179 | 1,051 | 1,121 | 1,038 | +25.3% |
| Other income | 10.22 | 9.31 | 9.42 | 10.81 | 11.22 | -8.9% |
| Total income | 1,310 | 1,188 | 1,060 | 1,132 | 1,049 | +24.9% |
| Profit before tax | 141 | 112 | 65.43 | 92.94 | 99.83 | +41.1% |
| Tax | 35.04 | 25.27 | 18.51 | 23.39 | 24.67 | +42.0% |
| Net profit | 106 | 86.44 | 46.90 | 69.47 | 75.10 | +40.9% |
| Net margin | 8.1% | 7.3% | 4.5% | 6.2% | 7.2% |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | FY24 Apr 2023–Mar 2024 | FY23 Apr 2022–Mar 2023 | FY22 Apr 2021–Mar 2022 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 4,388 | 4,178 | 4,136 | 4,773 | 4,949 | +5.0% |
| Other income | 40.53 | 37.82 | 35.30 | 33.37 | 31.49 | +7.2% |
| Total income | 4,429 | 4,215 | 4,171 | 4,806 | 4,981 | +5.1% |
| Profit before tax | 370 | 344 | 268 | 437 | 709 | +7.7% |
| Tax | 91.84 | 92.44 | 84.72 | 129 | 232 | -0.6% |
| Net profit | 278 | 251 | 183 | 308 | 477 | +10.6% |
| Net margin | 6.3% | 6.0% | 4.4% | 6.4% | 9.6% |
BIC's take
We haven't covered Jubilant Ingrevia Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 6:03 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.